As part of its Air ThermoDirect expansion, DSV has opened a dedicated air corridor for temperature-sensitive pharmaceuticals travelling between Luxembourg and Indianapolis. This move allows the elimination of active cooling containers since it focuses on improved temperature control throughout, including cutting time in uncontrolled environments. In removing the need for containers, the direct route enables a reduction in costs and emissions and simplifies handling processes – USPs that are particularly important in Indianapolis which is among the U.S.’ fastest-growing life sciences hubs. Luxembourg is equally critical to the global pharmaceutical supply chain, and the launch of this dedicated route offers “a cold chain that is predictable and scalable, while actively minimizing the environmental impact through optimized handling and more sustainable thermal solutions”. The move reflects a broader shift in healthcare logistics. DSV says successful healthcare logistics now depends on control, consistency, and true end-to-end ownership, not just access to capacity.
Kenneth Källström, Executive Vice President, Global Head, Healthcare, DSV, commented: “The DSV Indianapolis operations will play a pivotal role in the global Air ThermoDirect healthcare network, enhancing end-to-end visibility and control across pharma manufacturing regions in the US, Europe, the Americas, and APAC. By strengthening these critical supply-chain connections, this hub will help ensure that life-saving therapies move with greater speed, reliability, and integrity – ultimately delivering better outcomes for patients worldwide.”
Stephanie Penarete, Vice President Air Product Americas, DSV, said: “Indy Wings reflects our strategy to bring the critical points of the supply chain under full accountability, ensuring reliability, integrity and performance where it matters most. With Indy Wings, we continue linking key pharmaceutical hubs with greater precision, resilience and excellence.”
